E. UGURER Et Al. , "Undesirable repigmentation in vitiligo patient receiving methotrexate therapy for the treatment of psoriasis: treatment or side effect?," DERMATOLOGY ONLINE JOURNAL , vol.28, no.1, 2022
UGURER, E. Et Al. 2022. Undesirable repigmentation in vitiligo patient receiving methotrexate therapy for the treatment of psoriasis: treatment or side effect?. DERMATOLOGY ONLINE JOURNAL , vol.28, no.1 .
UGURER, E., ALTUNAY, İ. K., ERDEM, Y., ÖZKUR, E., & TUNÇEL, D., (2022). Undesirable repigmentation in vitiligo patient receiving methotrexate therapy for the treatment of psoriasis: treatment or side effect?. DERMATOLOGY ONLINE JOURNAL , vol.28, no.1.
UGURER, ECE Et Al. "Undesirable repigmentation in vitiligo patient receiving methotrexate therapy for the treatment of psoriasis: treatment or side effect?," DERMATOLOGY ONLINE JOURNAL , vol.28, no.1, 2022
UGURER, ECE Et Al. "Undesirable repigmentation in vitiligo patient receiving methotrexate therapy for the treatment of psoriasis: treatment or side effect?." DERMATOLOGY ONLINE JOURNAL , vol.28, no.1, 2022
UGURER, E. Et Al. (2022) . "Undesirable repigmentation in vitiligo patient receiving methotrexate therapy for the treatment of psoriasis: treatment or side effect?." DERMATOLOGY ONLINE JOURNAL , vol.28, no.1.
@article{article, author={ECE UGURER Et Al. }, title={Undesirable repigmentation in vitiligo patient receiving methotrexate therapy for the treatment of psoriasis: treatment or side effect?}, journal={DERMATOLOGY ONLINE JOURNAL}, year=2022}